As reported earlier, BMO Capital analyst Matt Borsch downgraded Universal Health to Market Perform from Outperform and lowered his price target to $125 from $130. The analyst believes that the persistence of tougher-than-expected fundamentals in the company's behavioral care business, including an "unfavorable payer mix shift and labor cost pressures", will weigh on the company's revenue and earnings growth. Borsch also remains constructive on Universal Health's "conservative" balance sheet and strong free cash flow, which will give the company some flexibility in terms of capital deployment.